Product
TCA-IR
1 clinical trial
1 indication
Indication
Shoulder OsteoarthritisClinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Single-dose Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral OsteoarthritisStatus: Recruiting, Estimated PCD: 2025-08-01